Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

36,447 stories, page 130 of 608

Advanced search

🌍Sep 2discoverynews.google.com

Flexible Tablet Coaters: Syntegon's Sepion 75 Scales Pharmaceutical Batch Processing

Trend HunterOriginal source

🌍Sep 2discoverynews.google.com

Employees rise with yeast, biotech giant

China DailyOriginal source

🌍Sep 2discoverynews.google.com

Biotech firm buys former Merrimack Anheuser-Busch brewery for $47 million

Nashua Ink LinkOriginal source

🌍Sep 2discoverynews.google.com

Biotech firm buys former Merrimack Anheuser-Busch brewery for $47 million

Manchester Ink LinkOriginal source

🌍Sep 2discoverynews.google.com

Citizens upgrades Ideaya Biosciences stock rating on IDE849 progress By Investing.com

Investing.com AustraliaOriginal source

🌍Sep 2discoverynews.google.com

The Bull Case For Legend Biotech (LEGN) Could Change Following Its CAR-T Scale-Up And In Vivo Pivot

simplywall.stOriginal source

🌍Sep 2discoverynews.google.com

Perspective Therapeutics: 'Strong Buy' On Bamzireotide Navoxetan Reinforced Data And Phase 3 Plans

Seeking AlphaOriginal source

🌍Sep 2discoverynews.google.com

Up to 75% of prostate biopsies are negative. Telix enrolled 350 patients.

Stock TitanOriginal source

🌍Sep 2discoverynews.google.com

Federal Judge Delays Mifepristone Lawsuit Until After Midterms

National Catholic RegisterOriginal source

🌍Sep 2discoverynews.google.com

Passive stake disclosed in Fortress Biotech (NASDAQ: FBIO) by Millennium group

Stock TitanOriginal source

🌍Sep 2discoverynews.google.com

State challenge to policy permitting mifepristone by mail paused until after midterms

OSV NewsOriginal source

🇪🇸Sep 2Researchcnic.es

European Journal of Heart Failure: Un medicamento para la diabetes reduce las complicaciones tras el reemplazo de la válvula aórtica

CNIC Spain CardiovascularOriginal source

🌍Sep 2discoverynews.google.com

Chattanooga company turns amniotic membranes into powerful grafts

Chattanooga Times Free PressOriginal source

🌍Sep 2discoverynews.google.com

Federal judge pauses mifepristone lawsuit amid FDA safety review

WWMTOriginal source

🌍Sep 2discoverynews.google.com

Intelligent Bio Solutions Advances Fingerprint Drug Test Toward FDA

TipRanksOriginal source

🌍Sep 2discoverynews.google.com

Lineage Cell Therapeutics: Balancing An Out-Licensed Pipeline Against Clinical Risk

Seeking AlphaOriginal source

🌍Sep 2discoverynews.google.com

'Without Guardrails': Are abortion pill companies putting profit over safety rules?

liveaction.orgOriginal source

🌍Sep 2discoverynews.google.com

TraceIQ Launched to Maximize Pharmaceutical Traceability

Genetic Engineering and Biotechnology NewsOriginal source

🌍Sep 2discoverynews.google.com

FDA drafts guidance on assessing impact of hepatic impairment on drug PK/PD

RAPSOriginal source

🌍Sep 2discoverynews.google.com

Krystal Biotech (KRYS) Pipeline Narrative Keeps Valuation In Focus After Recent Run Up

simplywall.stOriginal source

🌍Sep 2discoverynews.google.com

Spring is the time for footy finals, swooping magpies … and clinical trial results

NT NewsOriginal source

🌍Sep 2discoverynews.google.com

Verrica Advances Wart Drug Expansion as Phase 3 Trial Fills

MyChesCoOriginal source

🌍Sep 2discoverynews.google.com

US states' lawsuit seeking to curb abortion drug access paused for now

ReutersOriginal source

🌍Sep 2discoverynews.google.com

Heart-Drug Breakthroughs Can’t Stop Biotech Stocks From Sliding

Barron'sOriginal source

🌍Sep 2discoverynews.google.com

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

manilatimes.netOriginal source

🌍Sep 2Mediabrainsway.com

Repetitive transcranial magnetic stimulation in stroke rehabilitation: review of the current evidence and pitfalls

BrainsWayOriginal source

🌍Sep 2discoverynews.google.com

FDA response expected by mid-September for aTyr’s lung disease trial

Stock TitanOriginal source

🌍Sep 2Mediashoulderinnovations.com

Shoulder Innovations to Participate in the Morgan Stanley 24th Annual Healthcare Conference

Shoulder Innovations (ProVoyance + Micro-Robotic)Original source

🌍Sep 2Mediabrainsway.com

Repetitive transcranial magnetic stimulation of the primary motor cortex in stroke survivors-more than motor rehabilitation: A mini-review

BrainsWayOriginal source

🌍Sep 2discoverynews.google.com

Mounjaro (Tirzepatide): Side Effects, Risks & FDA Warnings

Drugwatch.comOriginal source

🌍Sep 2discoverynews.google.com

Abortion pill lawsuit delayed again, until as late as December

liveaction.orgOriginal source

🌍Sep 2discoverynews.google.com

GP-led walk-in pilot could duplicate existing services, says Royal College of Pharmacy

The Pharmaceutical JournalOriginal source

🌍Sep 2discoverynews.google.com

Government ‘intends to explore’ expanding advance payments to pharmacy students

The Pharmaceutical JournalOriginal source

🌍Sep 2discoverynews.google.com

Best practice for clopidogrel prescribing

The Pharmaceutical JournalOriginal source

🇺🇸Sep 2Devicesorthopediatrics.com

Pediatric Plating Platform™ | Hip (Trauma)

OrthoPediatricsOriginal source

🇮🇹Sep 2Researchpoliclinico.mi.it

#LavoraConNoi. Cercasi Research Assistant per Progetto di Ricerca Multi-Omica. Ultimi giorni per candidarsi!

Policlinico di MilanoOriginal source

🌍Sep 2discoverynews.google.com

Oculis doses first patient in phase 3 privosegtor trial for ON

Glance by Eyes On EyecareOriginal source

🌍Sep 2Industrynews.intermountainhealth.org

Pacientes de trasplante, médicos y empleados de cuatro hospitales celebran el 40.o aniversario del Programa de Trasplante Cardíaco de UTAH, un modelo nacional de colaboración

<![CDATA[Intermountain Health Newsroom]]>Original source

🌍Sep 2discoverynews.google.com

5 GLP-1 Trends to Expect in 2026: Expanded Uses, Oral Options, and More

GoodRxOriginal source

🌍Sep 2discoverynews.google.com

ESC 2026: Tirzepatide 5mg sustains cardiometabolic benefit with weight maintenance

Pharmaceutical TechnologyOriginal source

🌍Sep 2discoverynews.google.com

BYUH Intern Represents an International Agency at Asia's Premier Biotech Conference

BYU–Hawaii NewsOriginal source

🌍Sep 2discoverynews.google.com

ESC: Alnylam's next-gen silencer sees silver linings after fallout of AZ, Ionis trial in ATTR-CM

Fierce BiotechOriginal source

🌍Sep 2discoverynews.google.com

Could Your DNA Predict a Dangerous Drug Reaction?

MedShadow FoundationOriginal source

🌍Sep 2discoverynews.google.com

Are Sickle Cell Pain Trials Asking the Wrong Question? STArT Investigator Examines Current End Points

Pharmacy TimesOriginal source

🌍Sep 2discoverynews.google.com

A Lupus Drug Was a Failure and This Biotech Stock Is Down 58% Because of It

Barron'sOriginal source

🌍Sep 2discoverynews.google.com

Eli Lilly to Buy Immunology Biotech Merida Biosciences in $2.9B Deal

Yahoo FinanceOriginal source

🌍Sep 2discoverynews.google.com

Why Is Novartis Stock Soaring Tuesday? - Novartis (NYSE:NVS)

BenzingaOriginal source

🌍Sep 2discoverynews.google.com

Top Biotech Stocks Worth Watching - September 1st

MarketBeatOriginal source

🇧🇪Sep 2Regulatoryfamhp.be

Dépassements de quotas : l’AFMPS poursuit ses travaux et renforce la transparence

FAMHP BelgiumOriginal source

🌍Sep 2discoverynews.google.com

Federal judge pauses mifepristone lawsuit amid FDA safety review

local21news.comOriginal source

🌍Sep 2discoverynews.google.com

Myriad Genetics Stock Gets Double-Downgrade as Profitability Concerns Grow

Barron'sOriginal source

🌍Sep 2discoverynews.google.com

THX Pharma Files Phase 3 Trial Applications for Batten-1 in the United States, United Kingdom, and EU

Idéal InvestisseurOriginal source

🌍Sep 2discoverynews.google.com

The Next Biotech Boom May Be Cancer Vaccines. Watch These ETFs - Moderna (NASDAQ:MRNA)

BenzingaOriginal source

🌍Sep 2discoverynews.google.com

Why CMC readiness is becoming central to biopharma licensing deals

Clinical Trials ArenaOriginal source

🌍Sep 2discoverynews.google.com

Why CMC readiness is becoming central to biopharma licensing deals

clinicaltrialsarena.comOriginal source

🌍Sep 2discoverynews.google.com

THX Pharma, BBDF and Biocodex Announce Regulatory Submissions for the Phase 3 Clinical Trial of Batten-1 in…

ActusNews.comOriginal source

🌍Sep 2discoverynews.google.com

THX Pharma, BBDF and Biocodex Announce Regulatory Submissions for the Phase 3 Clinical Trial of Batten-1 in…

ActusNews.comOriginal source

🌍Sep 2discoverynews.google.com

THX Pharma, BBDF and Biocodex Announce Regulatory Submissions for the Phase 3 Clinical Trial of Batten-1 in…

ActusNews.comOriginal source

🌍Sep 1discoverynews.google.com

Federal judge pauses mifepristone lawsuit amid FDA safety review

WSMHOriginal source

🌍Sep 1discoverynews.google.com

Federal judge pauses mifepristone lawsuit amid FDA safety review

WJLAOriginal source